CORT:earlier this year, Cushing's Syndrome and drug to treat hallucinations were in the news. https://investorshub.advfn.com/boards/read_msg.aspx?message_id=139962151 I have not checked recently to see whether TEVA is still around with its patent challenge...must be a different patent involved there. CORT is a long-time holding for us; followed Amylin investors/money there.